The S&P Healthcare Services Index decreased by 2.4% over the last month, compared to the S&P 500 Index, which increased 1.5% over the same period.
Over the past month, the sectors that experienced the most growth were clinical laboratories (up 6.2%), HCIT (up 3.7%) and healthcare REITS (up 2.2%).
The sectors that experienced the largest declines were assisted / independent living (down 14.2%), rehabilitation (down 10.9%) and acute care hospitals (down 10.0%).
The current average Last Twelve Months (LTM) revenue and LTM EBITDA multiples for the healthcare services industry overall are 1.74x and 10.9x, respectively.
The sectors with the highest valuation multiples include:
- Home health / hospice (2.6x LTM revenue, 21.9x LTM EBITDA)
- Hospital vendors (1.85x LTM revenue, 20.7x LTM EBITDA
- HCIT (4.92x LTM revenue, 19.7x LTM EBITDA)
- Consumer directed health / wellness (2.64x LTM revenue, 18.2x LTM EBITDA)
Comprehensive support throughout mergers and acquisitions and other corporate transactions.
Healthcare expertise for middle-market M&A transactions.
Middle-market M&A advisory differentiated by industry expertise and superior deal execution.
Fairness and Solvency Opinions
Independent opinions for boards of directors and special committees.
Financial Sponsors Group
Dedicated coverage and access to M&A deal-flow for financial sponsors.
Distressed M&A and Special Situations
Financial and operational solutions for distressed and special situations.
Private Capital Markets
Senior, subordinated and mezzanine debt and venture/private equity for a wide range of transactions.